Feedback AAD 2018

Conference Summaries

Clinical Trials

Apremilast for Behçet's Syndrome: A Phase III Randomized, Placebo-Controlled, Double-Blind Study (RELIEF)

Yusef Yazici, MD

Clinical Trials

Efficacy and Safety of IFX-1, an Anti-C5a Monoclonal Antibody, in a Open-Label, Phase 2A Study in Patient with Severe Hidradenitis Suppurative not Eligible for Adalimumab

Evangelos J. Giamarellos-Bourboulis, MD, PhD

Clinical Trials

A Pilot Phase 2a Study of the Safety and Efficacy of Berilimumab (an Anti-Eotaxin-1 Antibody) in Bullous Pemphigoid

Sharon A. Baum, MD

Acne

Acne: What's New

Hillary E. Baldwin, MD, FAAD

Atopic Dermatitis

An Update on Topical Therapy for Atopic Dermatitis

Amy S. Paller, MD, FAAD

Atopic Dermatitis

A Cytokine-Driven Systemic Disease with Implications for Therapeutics

Emma Guttman, MD, PhD, FAAD

Atopic Dermatitis

Atopic Dermatitis: New Developments

Lawrence F. Eichenfield, MD, FAAD

Cosmetic and Cosmeceuticals

Cosmeceuticals: Naturally Absurd

Zoe Diana Draelos, MD, FAAD

Cosmetic and Cosmeceuticals

Hot Topics in Cosmetic Dermatology

Anthony V. Benedetto, DO, FAAD

Cutaneous Oncology, Melanoma

2018 Skin Tumors in Children

Jane M. Grant-Kels, MD, FAAD

Cutaneous Oncology, Melanoma

Melanoma Update 2018

Allan C. Halpern, MD, FAAD

Cutaneous Oncology, Melanoma

Strategies in the Current Management of Melanoma

Daniel Ethan Zelac, MD, FAAD

Hair

Hairy Matters: What’s New in Alopecia

Wilma Fowler Bergfeld, MD, FAAD

Infectious Diseases

HIV in 2018

Kieron S. Leslie, MD, MBBS, MRCP, DTM&H

Infectious Diseases

Adventures in Syphilis

Theodore Rosen, MD, FAAD

Pediatric

How do I Choose a Systemic Agent for Psoriasis?

Amy S. Paller, MD, FAAD

Psoriasis

Current and Emerging Biologic Therapies for Psoriatic Arthritis

Alice B. Gottlieb, MD, FAAD

Psoriasis

Biologics and Psoriasis: the Beat Goes On

Mark Lebwohl, MD, FAAD
Download the AAD 2018 Slide Kit